v3.26.1
Consolidated Statements of Changes In Stockholders’ Equity - USD ($)
Common stock
Additional Paid In Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 316 $ 17,525,714 $ (471,121) $ (6,227) $ (10,871,811) $ 6,176,871
Balance (in Shares) at Dec. 31, 2023 3,159,096          
Balance (in Shares) at Dec. 31, 2023     252,855      
Purchase of treasury stock $ (173,113) (173,113)
Purchase of treasury stock (in Shares) 102,855   102,855      
Sale of common stock and pre-funded warrants $ 89 1,673,127 1,673,216
Sale of common stock and pre-funded warrants (in Shares) 883,395          
Exercise of pre-funded warrants $ 3 3
Exercise of pre-funded warrants (in Shares) 34,037          
Sale of common stock and warrants, net of issuance costs $ 76 1,741,446 1,741,522
Sale of common stock and warrants, net of issuance costs (in Shares) 763,638          
Cancellation of treasury stock $ (35) (644,199) $ 644,234
Cancellation of treasury stock (in Shares) (355,710)   (355,710)      
Accumulated other comprehensive gain - short-term investments 8,646 8,646
Net loss (4,392,880) (4,392,880)
Balance at Dec. 31, 2024 $ 449 20,296,088 2,419 (15,264,691) 5,034,265
Balance (in Shares) at Dec. 31, 2024 4,484,456          
Balance (in Shares) at Dec. 31, 2024          
Sale of common stock, net of offering costs and expenses of $774,705 $ 558 3,358,738 3,359,296
Sale of common stock, net of offering costs and expenses of $774,705 (in Shares) 5,580,479          
Sale of pre-funded warrants 365,940 365,940
Exercise of warrants for cash, net of offering costs $ 250 1,134,733 1,134,983
Exercise of warrants for cash, net of offering costs (in Shares) 2,503,338          
Issuance of common stock in exchange of acquired technology, net of offering costs of $25 $ 75 518,150 518,225
Issuance of common stock in exchange of acquired technology, net of offering costs of $25 (in Shares) 750,000          
Accretion of stock-based compensation in connection with stock option grants 117,021 117,021
Accumulated other comprehensive gain - short-term investments 3,409 3,409
Net loss (4,227,698) (4,227,698)
Balance at Dec. 31, 2025 $ 1,332 $ 25,790,670 $ 5,828 $ (19,492,389) $ 6,305,441
Balance (in Shares) at Dec. 31, 2025 13,318,273          
Balance (in Shares) at Dec. 31, 2025